Caplight Directory>Investors>RYSE Asset Management>Ryseam


RYSE Asset Management

RYSE Asset Management

London, Englandryseam.com

Overview

RYSE Asset Management is a venture capital firm headquartered in London, specializing in early-stage (Seed and Series A) HealthTech investments. The firm focuses on transformative technologies in underserved areas to drive both impact and commercial returns, targeting unmet clinical needs and aiming to improve healthcare access and affordability. Its investment areas include digital diagnostics, digital therapeutics, medical devices, and data platforms, with expertise in cardiovascular health, metabolic disorders, oncology, mental health, women's health, and health AI. RYSE collaborates with industry partners like the NHS, Novartis, and Medtronic to help scale its portfolio companies. In March 2024, the firm announced the first close of a US$50 million Special Opportunities Fund.

Portfolio Companies

4

Website

ryseam.com

Investments

CompanyDateStageLead
Ten63 TherapeuticsFeb 2026StrategicCo-investor
Ten63 TherapeuticsFeb 2026StrategicCo-investor
Curio Digital TherapeuticsAug 2024Series ALead
BraingazeMar 2024SeedLead
Log my CareAug 2020SeedCo-investor

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersLondon, England
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.